Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8-c-beta-glucopyranosyl-3',4',5,7-tetrahydroxyflav-2-en-3-one
2. Luteolin 8-c-beta-d-glucopyranoside
3. Luteolin-8-c-glucoside
4. Orientine
1. 28608-75-5
2. Lutexin
3. Luteolin 8-c-glucoside
4. Orientine
5. Luteolin-8-glucoside
6. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-
7. 8-beta-d-glucosylluteolin
8. Iax93xcw6c
9. Luteolin 8-glucoside
10. Chebi:7781
11. 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
12. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)-4h-chromen-4-one
13. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
14. C10114
15. Orientin (flavone)
16. 8-glucosylluteolin
17. Luteolin-8-c-glucoside
18. 2-(3,4-dihydroxyphenyl)-8-beta-d-glucopyranosyl-5,7-dihydroxy-4h-chromen-4-one
19. 4h-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-
20. Unii-iax93xcw6c
21. Nsc-133101
22. Use
23. Mfcd00017432
24. 8-.beta.-d-glucopyranosyl-3',4',5,7-tetrahydroxyflavone
25. Schembl25942
26. Orientin, Analytical Standard
27. Massbank Pr020063
28. Chembl520866
29. Orientin, >=97% (hplc)
30. Bdbm84982
31. Dtxsid60182790
32. Luteolin 8-c-b-d-glucopyranoside
33. Niaid Aids# 026706
34. Hms3886j16
35. Hy-n0405
36. Zinc4098560
37. 8-.beta.-d-glucosylluteolin
38. S9099
39. Akos015896746
40. Ccg-269214
41. Ncgc00482848-01
42. Ac-34280
43. As-73888
44. J17.734b
45. Luteolin 8-c-.beta.-glucopyranoside
46. Cs-0008937
47. O0503
48. Luteolin 8-c-.beta.-d-glucopyranoside
49. 608o755
50. A819507
51. Orientin, Primary Pharmaceutical Reference Standard
52. Q421676
53. 8-b-d-glucopyranosyl-3',4',7'-tetrahydroxyflavone
54. Q-100362
55. 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-4h-chromen-4-one
56. (1s)-1,5-anhydro-1-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-8-yl)-d-glucitol
57. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(.beta.-d-glucopyranosyl)-4h-1-benzopyran-4-one
58. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-4h-chromen-4-one
59. 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]chromen-4-one
60. 2-(3,4-dihydroxyphenyl)-8-.beta.-d-glucopyranosyl-5,7-dihydroxy-4h-1-benzopyran-4-one
61. 2-[3,4-bis(oxidanyl)phenyl]-8-[(2~{s},3~{r},4~{r},5~{s},6~{r})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]-5,7-bis(oxidanyl)chromen-4-one; 5281675; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
62. 8-(.beta.-d-glucopyranosyl)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
63. D-glucitol, 1,5-anhydro-1-c-(2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-1-benzopyran-8-yl)-, (1s)-
Molecular Weight | 448.4 g/mol |
---|---|
Molecular Formula | C21H20O11 |
XLogP3 | -0.2 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 3 |
Exact Mass | 448.10056145 g/mol |
Monoisotopic Mass | 448.10056145 g/mol |
Topological Polar Surface Area | 197 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 729 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?